TW202313608A - 2,8—二氮雜螺[4.5]癸烷化合物 - Google Patents

2,8—二氮雜螺[4.5]癸烷化合物 Download PDF

Info

Publication number
TW202313608A
TW202313608A TW111120777A TW111120777A TW202313608A TW 202313608 A TW202313608 A TW 202313608A TW 111120777 A TW111120777 A TW 111120777A TW 111120777 A TW111120777 A TW 111120777A TW 202313608 A TW202313608 A TW 202313608A
Authority
TW
Taiwan
Prior art keywords
alkyl
compound
group
hydrogen
independently selected
Prior art date
Application number
TW111120777A
Other languages
English (en)
Chinese (zh)
Inventor
史蒂芬 約翰 麥可羅
艾莉絲 羅斯 王
詹姆士 約翰 奎福特
溫蒂 李
賴光華
古勞梅 皮勒提爾
史蒂芬 羅伊
戴娜 克里斯汀 維特
奥村美樹子
路思 朵瑞爾
Original Assignee
美商建南德克公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商建南德克公司 filed Critical 美商建南德克公司
Publication of TW202313608A publication Critical patent/TW202313608A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pens And Brushes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
TW111120777A 2021-06-04 2022-06-03 2,8—二氮雜螺[4.5]癸烷化合物 TW202313608A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2021098358 2021-06-04
WOPCT/CN2021/098358 2021-06-04

Publications (1)

Publication Number Publication Date
TW202313608A true TW202313608A (zh) 2023-04-01

Family

ID=84322789

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111120777A TW202313608A (zh) 2021-06-04 2022-06-03 2,8—二氮雜螺[4.5]癸烷化合物

Country Status (11)

Country Link
US (1) US20240174696A1 (https=)
EP (1) EP4347594A4 (https=)
JP (1) JP2024521929A (https=)
KR (1) KR20240016977A (https=)
CN (1) CN117425654A (https=)
AR (1) AR126078A1 (https=)
AU (1) AU2022284188A1 (https=)
BR (1) BR112023025393A2 (https=)
CA (1) CA3222054A1 (https=)
TW (1) TW202313608A (https=)
WO (1) WO2022253341A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101679418A (zh) * 2007-04-06 2010-03-24 诺瓦提斯公司 用作蛋白质激酶抑制剂的[2,6]萘啶类化合物
JP2011529932A (ja) * 2008-08-05 2011-12-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ナフチリジン及び医薬としてのその使用
WO2012167423A1 (en) * 2011-06-08 2012-12-13 Hutchison Medipharma Limited Substituted pyridopyrazines as novel syk inhibitors
KR20140048216A (ko) * 2011-06-29 2014-04-23 오츠카 세이야쿠 가부시키가이샤 치료 화합물로서의 퀴나졸린 및 관련된 사용 방법
TWI675836B (zh) * 2014-03-25 2019-11-01 美商伊格尼塔公司 非典型蛋白質激酶c之氮雜喹唑啉抑制劑
JOP20190257A1 (ar) * 2017-04-28 2019-10-28 Novartis Ag مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats
KR102328435B1 (ko) * 2018-09-11 2021-11-18 재단법인 대구경북첨단의료산업진흥재단 신규 피리도-피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
WO2021050059A1 (en) * 2019-09-11 2021-03-18 Provincial Health Services Authority Dna-pk inhibiting compounds

Also Published As

Publication number Publication date
CN117425654A (zh) 2024-01-19
AU2022284188A1 (en) 2023-11-30
WO2022253341A1 (en) 2022-12-08
AR126078A1 (es) 2023-09-06
EP4347594A1 (en) 2024-04-10
BR112023025393A2 (pt) 2024-02-27
KR20240016977A (ko) 2024-02-06
US20240174696A1 (en) 2024-05-30
JP2024521929A (ja) 2024-06-04
EP4347594A4 (en) 2025-06-18
CA3222054A1 (en) 2022-12-08

Similar Documents

Publication Publication Date Title
KR102682323B1 (ko) Shp2 억제제 및 이의 용도
EP3480198B1 (en) Novel compound or pharmaceutically acceptable salt thereof
JP2021518441A (ja) Shp2ホスファターゼ阻害剤およびこれらの使用方法
CA3092770A1 (en) Substituted imidazolidin-2-one derivatives as prmt5 inhibitors
TW202409030A (zh) 五元並六元含氮化物、其中間體、製備方法和應用
JP2013501002A (ja) Sykキナーゼ阻害剤としての化合物および組成物
JP2021506979A (ja) ホスファチジルイノシトールリン酸キナーゼ阻害剤としてのアリール−ビピリジンアミン誘導体
JP7840334B2 (ja) 芳香族複素環式化合物、薬学的組成物、及びその使用
EP4303216A1 (en) Fused ring substituted six-membered heterocyclic compound, preparation method therefor and use thereof
KR20220018483A (ko) 비스헤테로사이클릭 카보닐 치환된 디하이드로피라졸 화합물, 이의 제조방법 및 이의 약학적 용도
JP2019530740A (ja) ピリジン並びに5員芳香環系化合物、その製造方法及び使用
US20210363130A1 (en) Heterocyclic compound
TW202345797A (zh) 作為ikzf2降解劑之含雙環雜芳基化合物
EP4558502A1 (en) Aza-quinazoline compounds and methods of use
KR20240052797A (ko) Egfr 억제제로서의 치환된 아미노피리딘 화합물
TW202340211A (zh) 嘧啶雜環化合物、其製法與醫藥上的用途
US20140121231A1 (en) Pyranopyridone inhibitors of tankyrase
TW202313608A (zh) 2,8—二氮雜螺[4.5]癸烷化合物
TW202345794A (zh) 依莫帕米結合蛋白抑制劑及其用途
TWI912370B (zh) 芳香雜環類化合物、藥物組合物及其應用
WO2026024686A1 (en) Kinase modulators and methods of use thereof
HK40101182A (zh) 2,8-二氮杂螺[4.5]癸烷化合物
TW202506690A (zh) 吡唑并吡啶衍生化合物及其用途
JP2025526462A (ja) ハンチントン病を治療するための化合物
CN115557946A (zh) 杂环内酰胺类化合物,包含其的药物组合物及其用途